Heidi Isokääntä Successfully Defends Dissertation on Gut Microbiome Development
Heidi Isokääntä Successfully Defends Dissertation on Gut Microbiome Deveopment
Turku, 26 September 2025 – Bioanalyst Heidi Isokääntä has successfully defended her doctoral dissertation in medical microbiology at the University of Turku. The defense took place on 26 September 2025, from 12:00 to 16:00 in the Osmo Järvi Hall, Medisiina C, Chinamyllynkatu 10, Turku.
Her dissertation, titled “Utilization of Next Generation Sequencing and Metabolomics in Human Microbiome Studies: Optimized Laboratory Methods and Exploratory Findings on Gut Microbiome and Metabolome Development in Early Life”, examined innovative laboratory methods and offered new insights into the development of gut microbiota and metabolism in early childhood. It also highlighted the application of next-generation omics techniques in clinical microbiota research.
The dissertation was publicly examined by Docent Mikael Niku (University of Helsinki), with Docent Alex Dickens (University of Turku) serving as custos. The defense was conducted in Finnish.
Heidi Isokääntä’s research provides valuable contributions to understanding human microbiome development and its implications for early-life health.
Dissertation in the University’s Publications Archive: https://urn.fi/URN:ISBN:978-952-02-0290-3

Recent Posts
- Meet our SAB over lunch!Turku Bioscience and BioCity Turku Scientific Advisory Board (SAB) is visiting Turku next week, and Read moreSeptember 16, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026